ISSN:

Journal Home

EBioMedicine Q1 Unclaimed

Elsevier B.V. Netherlands

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

EBioMedicine is a journal indexed in SJR in Medicine (miscellaneous) and Biochemistry, Genetics and Molecular Biology (miscellaneous) with an H index of 136. It is an CC BY-NC-ND Journal with a Single blind Peer Review review system, and It has a price of 2700 €. The scope of the journal is focused on basic science, clinical science, translational, genetics, drug targeting, biomedicine. It has an SJR impact factor of 3,591 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 3,591.

EBioMedicine focuses its scope in these topics and keywords: auditory, human, patients, rna, state, treatment, amplifies, anticancer, arginine, arpkd, ...

Type: Journal

Type of Copyright: CC BY-NC-ND

Languages: English

Open Access Policy: Open Access

Type of publications:

Publication frecuency: -

Categories: Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q1) Medicine (miscellaneous) (Q1)

Price

2700 €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

3,591

SJR Impact factor

136

H Index

561

Total Docs (Last Year)

1701

Total Docs (3 years)

30168

Total Refs

14633

Total Cites (3 years)

1335

Citable Docs (3 years)

9.52

Cites/Doc (2 years)

53.78

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

MMWR. Morbidity and mortality weekly report Q1
Annual Review of Public Health Q1
Annual Review of Clinical Psychology Q1
Journal of Thoracic Oncology Q1
Lancet Digital Health, The Q1

Compare this journals